On The Pen With Dave Knapp
By Dave Knapp Man On The Mounjaro, Bleav
Listen to a podcast, please open Podcast Republic app. Available on Google Play Store and Apple App Store.
Category: Medicine
Open in Apple Podcasts
Open RSS feed
Open Website
Rate for this podcast
Subscribers: 8
Reviews: 0
Episodes: 139
Description
Dave Knapp brings you your weekly dose of everything in the news about incretin mimetic, diabetes and obesity therapies, like Zepbound and Mounjaro, Ozempic and Wegovy, and even investigational treatments like CagriSema and Retatrutide!
| Episode | Date |
|---|---|
|
Zepbound Compound Lawsuit Update: Eli Lilly Vs Mochi
|
Aug 30, 2025 |
|
Eli Lilly VS Mochi Update + Big Lilly Orforglipron Secret Revealed
|
Aug 26, 2025 |
|
Ozempic Price Cut + New Obesity Pill Data
|
Aug 19, 2025 |
|
GLP-1 Microdosing For Weight Loss: Noom CEO Explains Their New Program
|
Aug 13, 2025 |
|
Eli Lilly Earnings Call Recap: Stock Tanks on Weight Loss Pill Miss
|
Aug 07, 2025 |
|
Novo Nordisk Blames Compound Semaglutide on Slower Sales
|
Aug 07, 2025 |
|
No Compounded Retatrutide Says the FDA + Tons of GLP-1 News
|
Aug 05, 2025 |
|
LEAKED TRUMP DOCUMENT: Medicare to Cover Zepbound and Wegovy for Obesity
|
Aug 01, 2025 |
|
Retatrutide Drops are Crazy // OTP TWD 7.29.25
|
Jul 29, 2025 |
|
Compound GLP-1 Injections : You Won't Believe What The Obesity Society is Saying
|
Jul 22, 2025 |
|
Connecticut Making Ozempic!? Meet The Mastermind
|
Jul 18, 2025 |
|
SHOCKING: How GLP-1 Protects the Heart Beyond Weight Loss // OTP TWD 7.25.25
|
Jul 15, 2025 |
|
BREAKING: Insurance Approving Mounjaro Over Zepbound!? What is Going On!?
|
Jul 08, 2025 |
|
Behind the Scenes of the Obesity Drug Battle | Obesity Action Coalition President Interview
|
Jul 05, 2025 |
|
Unlocking Zepbound Insurance Coverage + More GLP-1 Good News // otp twd 7.1.25
|
Jul 01, 2025 |
|
Lilly Could Lose Their Tirzepatide Patent! Plus ADA Coverage // OTP TWD 06.24.25
|
Jun 24, 2025 |
|
Faces of The Fight: The Jamie Selzler Story
|
Jun 23, 2025 |
|
Zepbound Vials Drop, Amycretin Surges, FDA Fast Track, and a Dangerous Trend // TWD 6.17.25
|
Jun 17, 2025 |
|
GLP-1 Access Progress + The Race for Less Frequent Dosing: OTP TWD 6.10.25
|
Jun 10, 2025 |
|
Lilly Makes Bold Move on GLP Dosing / 8x More Ozempic? / Wegovy Use in Teens
|
Jun 03, 2025 |
|
Trump Admin Setting Price Targets for Zepbound and Ozempic, Will Pharma Go Along?
|
May 20, 2025 |
|
Zepbound vs. Wegovy, CVS vs. Patients, and the Executive Order That Changes Everything
|
May 13, 2025 |
|
Compound Tirzepatide Lawsuit + PBM Reform Update // OTP TWD 5.6.25
|
May 06, 2025 |
|
CVS Drops Zepbound + Lilly Earnings Call Recap
|
May 01, 2025 |
|
Compound GLP-1 PubMed Data: What It Didn’t Tell Us
|
Apr 29, 2025 |
|
High Dose Semaglutide Incoming! How Much Will it Cost? // OTP TWD 4.22.25
|
Apr 22, 2025 |
|
Getting Insurance To Cover Skin Removal Surgery // OTP Eps 109
|
Apr 19, 2025 |
|
Counterfeit Ozempic at Pharmacies! // OTP TWD 4.15.25
|
Apr 15, 2025 |
|
GLP-1 Slow Responders: Dr Matthea Rentea // OTP Eps 108
|
Apr 11, 2025 |
|
Grow-Zempic!? These Students Discoverd a GLP-1 Plant!
|
Apr 11, 2025 |
|
Noom CEO Geoff Cook Interview: Wall Street Journal GLP-1 Cost Ad
|
Apr 09, 2025 |
|
GLP-1 Medicare Coverage: What is Going On // OTP TWD 04.08.2025
|
Apr 08, 2025 |
|
Are GLP-1 Meds For Life? Fractyl’s CEO Says “Not So Fast!”
|
Apr 06, 2025 |
|
Fake Sugar: 👍 or 👎 for Weight Loss With Dr. Spencer Nadolsky // OTP Eps 107
|
Apr 04, 2025 |
|
Tirzepatide Compounds: Lilly Sues Pharmacies // OTP TWD 04.01.25
|
Apr 01, 2025 |
|
Zepbound Weight Loss Stalls: Tips and Tricks // OTP Eps 106
|
Mar 29, 2025 |
|
Rare Exclusive Interview: OFA Chairman Sits Down with OTP to Talk Tirzepatide Lawsuit
|
Mar 26, 2025 |
|
Novo’s Retatrutide Competitor
|
Mar 25, 2025 |
|
Ozempic: Setting the Microdosing Strategy Straight w/ Dr Tyna Moore // OTP EPS 105
|
Mar 14, 2025 |
|
Compound Tirzepatide Latest // Cagrisema Disappoints Again // Great Vikingtide News
|
Mar 11, 2025 |
|
Obesity Bias in Medicine With Dr. Toomer // OTP Eps 104
|
Mar 07, 2025 |
|
Compound GLP-1 Accessibility + World Obesity Day // OTP TWD 03.04.25
|
Mar 04, 2025 |
|
Compound Tirzepatide Latest Updates // @Mike.OnAMssion2 Joins // OTP Eps 103
|
Feb 28, 2025 |
|
Lilly Drops Zepbound Price, Compounders Sue FDA (again) OTP TWD 2.25.25
|
Feb 25, 2025 |
|
Compound Tirzepatide Lawsuit Update / GLP-1 Heart Health w Dr Simin Lee / OTP Eps 102
|
Feb 21, 2025 |
|
503A Compound Tirzepatide Deadline Is Here, What Next? // OTP TWD 2.18.25
|
Feb 18, 2025 |
|
Zepbound Weight Loss and Cancer Diagnosis // OTP Eps 101
|
Feb 14, 2025 |
|
Lilly Announces Next Gen Tirzepatide
|
Feb 11, 2025 |
|
GLP-1 Talk Show: An Emotional 100th On The Pen Live
|
Feb 07, 2025 |
|
Zepbound and Retatrutide News: Lilly Q4 Earnings Call Recap
|
Feb 06, 2025 |
|
Novo Nordisk Q4 '24 Earnings Call: Obesity Medicine Implications
|
Feb 05, 2025 |
|
Like Retatrutide But In A Pill? OTP TWD 2.4.25
|
Feb 04, 2025 |
|
463 Pound Zepbound Weight Loss // OTP Eps 99
|
Feb 02, 2025 |
|
503b Compounder Rocked by FDA Audit + OFA v FDA Trial Update
|
Jan 30, 2025 |
|
Kelly Matthew of GLP1 Real Talk Joins! OTP Eps 97
|
Jan 27, 2025 |
|
Massive Zepbound and Wegovy News // OTP TWD 1.21.25
|
Jan 21, 2025 |
|
TikTok GLP-1 Refugees Episode
|
Jan 17, 2025 |
|
Compounders Win Small Battle in War Over Zepbound and Mounjaro Shortages
|
Jan 15, 2025 |
|
Legal Expert: Compound Tirzepatide Trial Update || OTP Eps 96
|
Jan 10, 2025 |
|
Generic Liraglutide and GLP-1 Accessibility
|
Jan 08, 2025 |
|
More Generic GLP-1 Options Hit The Market!
|
Dec 30, 2024 |
|
On The Pen: The Weekly Dose 12.17.24
|
Dec 17, 2024 |
|
An Inflatable Stomach Balloon for Weight Loss
|
Dec 16, 2024 |
|
A GLP-1 Monopoly In The Making: Biden Admin Fails to Act, Novo Acquires Catalent
|
Dec 14, 2024 |
|
OFA Representation in Compound Tirzepatide Case Sits Down with OTP
|
Dec 11, 2024 |
|
CagriSema Delay? Novo Catalent Update
|
Dec 11, 2024 |
|
American Diabetes Association on the Wrong Side of Compounded GLP-1 Meds
|
Dec 03, 2024 |
|
Like Ozempic, But You Only Take It Once! Fractyl Health CEO Dr. Harith Rajagopalan
|
Nov 29, 2024 |
|
Retatrutide Cagrisema & Obesity Medicine Future With Dr. Michael Albert
|
Nov 28, 2024 |
|
Medicare to Cover Zepbound and Wegovy?
|
Nov 26, 2024 |
|
Compound Tirzepatide Future + @FitFlavorFun : OTP EPS 91
|
Nov 23, 2024 |
|
On The Pen: The Weekly Dose 11.19.24
|
Nov 19, 2024 |
|
CNN Special: Is Ozempic For You? With Dr. Gupta OTP REVIEW
|
Nov 18, 2024 |
|
Dr Spencer Nadolsky: Docs Who Lift Pod | OTP Eps 90
|
Nov 15, 2024 |
|
Novo Nordisk's War on Compound Semaglutide, Maritide Has Some Negative News
|
Nov 12, 2024 |
|
Viking Therapeutics and AstraZeneca Steal The Show at Obesity Week!
|
Nov 05, 2024 |
|
Lilly Earnings Call Analysis: Why Zepbound Missed Earnings
|
Oct 31, 2024 |
|
New Zepbound Savings Card, GLP-1 Accessibility Landscape Evolves
|
Oct 29, 2024 |
|
Inside the Legal Battle for Compound Tirzepatide: What You Need to Know from Industry Insider Scott Brunner!
|
Oct 25, 2024 |
|
Tirzepatide Lawsuits Filed By Lilly, Catalent Reframing Novo Merger
|
Oct 22, 2024 |
|
Compounded Zepbound Legal Battle Landscape: Legal Expert Weighs In
|
Oct 18, 2024 |
|
Compounded Zepbound Uncertainty + Leveraging GLP-1 To Improve Labor Shortages
|
Oct 15, 2024 |
|
Heartbreaking Zepbound Story | OTP Eps 85
|
Oct 11, 2024 |
|
Tirzepatide Lawsuits + Ozempic Patent Victory
|
Oct 08, 2024 |
|
Megadosing Zepbound and Mounjaro With Dr. Daniel Rosen
|
Oct 04, 2024 |
|
Ozempic and Zepbound Supply Impacted by Port Worker Strike!
|
Oct 02, 2024 |
|
Amy Kane @AmyInHalf Discusses Dramatic Mounjaro Transformation
|
Sep 28, 2024 |
|
On The Pen: The Weekly Dose 9.24.24
|
Sep 24, 2024 |
|
Eli Lilly Compound Tirzepatide Letters + Retatrutide Trial Guest!
|
Sep 21, 2024 |
|
BCBS Demanding Refunds From Ozempic Prescribers? | The Weekly Dose 9.17.24
|
Sep 17, 2024 |
|
On The Pen: The Weekly Dose 9.10.24
|
Sep 10, 2024 |
|
Dr. Spencer Nadolsky On Compound Tirzepatide After Leaving Weight Watchers
|
Sep 06, 2024 |
|
Ozempic Shortages Extended | The Weekly Dose 9.3.24
|
Sep 03, 2024 |
|
Zepbound Savings Card & Zepbound Vials Discussion With The Downsized
|
Aug 30, 2024 |
|
Massive Zepbound Vials News 8.27.24
|
Aug 27, 2024 |
|
On The Pen: The Weekly Dose 8.20.24
|
Aug 19, 2024 |
|
On The Pen: The Weekly Dose 8.13.24
|
Aug 13, 2024 |
|
On The Pen: The Weekly Dose 8.6.24
|
Aug 06, 2024 |
|
On The Pen: The Weekly Dose 7.30.24
|
Jul 30, 2024 |
|
On The Pen: The Weekly Dose 7.23.24
|
Jul 22, 2024 |
|
On The Pen: The Weekly Dose 7.16.24
|
Jul 15, 2024 |
|
Amylin and the future of obesity medicine with Dr. Beverly Tchang
|
Jul 13, 2024 |
|
On The Pen: The Weekly Dose 7.9.24
|
Jul 08, 2024 |
|
On The Pen: The Weekly Dose 7.2.24
|
Jul 02, 2024 |
|
On The Pen: The Weekly Dose 6.25.24
|
Jun 25, 2024 |
|
On The Pen: The Weekly Dose 6.18.24
|
Jun 18, 2024 |
|
Zepbound And Liver Disease
|
Jun 12, 2024 |
|
On The Pen: The Weekly Dose 6.11.24
|
Jun 11, 2024 |
|
On The Pen: The Weekly Dose 6.4.24
|
Jun 04, 2024 |
|
OTP EPS 68: Ro CEO Zach Reitano Talks GLP-1 Supply Tracker
|
May 31, 2024 |
|
On The Pen: The Weekly Dose 5.28.24
|
May 28, 2024 |
|
On The Pen Live Eps 67: Survodutide Trial Participant Tells All!
|
May 25, 2024 |
|
On The Pen: The Weekly Dose 5.21.24
|
May 21, 2024 |
|
On The Pen: The Weekly Dose 5.14.24
|
May 14, 2024 |
|
Threats to Lilly's Zepbound & Mounjaro Printing Press
|
May 11, 2024 |
|
On The Pen: The Weekly Dose 5.7.24
|
May 08, 2024 |
|
Lilly Earnings Call: Zepbound and Mounjaro Updates
|
May 01, 2024 |
|
On The Pen: The Weekly Dose 4/30/24
|
Apr 30, 2024 |
|
On The Pen: The Weekly Dose 4/23/24
|
Apr 23, 2024 |
|
Zepbound Vials: The Business Case
|
Apr 19, 2024 |
|
On The Pen: The Weekly Dose 4/16/24
|
Apr 15, 2024 |
|
Sourcing Compound Tirzepatide
|
Apr 13, 2024 |
|
On The Pen: The Weekly Dose 4.9.24
|
Apr 09, 2024 |
|
Zepbound Single Dose Vials Approved!
|
Apr 01, 2024 |
|
On The Pen: The Weekly Dose 3/26/24
|
Mar 26, 2024 |
|
On The Pen: The Weekly Dose 3/19/24
|
Mar 19, 2024 |
|
Novo Nordisk Pipeline Obesity Medicines Announced
|
Mar 10, 2024 |
|
On The Pen: The Weekly Dose 3/5/24
|
Mar 05, 2024 |
|
Mounjaro to Zepbound and Beyond with Dr. Albert
|
Mar 01, 2024 |
|
On The Pen: The Weekly Dose 2/27/24
|
Feb 27, 2024 |
|
On The Pen: The Weekly Dose 2/20/24
|
Feb 20, 2024 |
|
Zepbound Mounjaro Ozempic News: 2.13.24
|
Feb 13, 2024 |
|
Q4 Eli Lilly Earnings Call Recap
|
Feb 07, 2024 |
|
On The Pen: The Weekly Dose 2.6.24
|
Feb 06, 2024 |
|
Q4 Novo Nordisk Earnings Call Recap
|
Feb 01, 2024 |
|
On The Pen: The Weekly Dose 1.30.24
|
Jan 30, 2024 |
|
On The Pen: The Weekly Dose 1.23.24
|
Jan 23, 2024 |
|
On The Pen: The Weekly Dose 1.16.24
|
Jan 16, 2024 |
|
On The Pen: The Weekly Dose Podcast!
|
Jan 14, 2024 |